UTHR: unither.com Expected earnings per share growth for next year

Public company logo of United Therapeutics (UTHR)

The stable management of United Therapeutics (UTHR) skillfully balances current revenues with long-term developments in organ engineering. Martin Rothblatt ensures transparent patent protection and implements xenotransplantation. The profit growth rate model for the coming year confirms these successes, where the latest parameter is 20.70. This strategy allows the company to diversify its biotech portfolio by creating artificial organs to save critically ill patients.

United Therapeutics Corp (UTHR): Net earnings per share change forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company United Therapeutics Corp (UTHR)

Fundamental company valuation:UTHR, unither.com
Finished products of United Therapeutics Corporation

Profit dynamics determine the market value of an asset through the expected return on equity. This indicator measures the percentage deviation of the projected profit for the coming year from current values, capturing analyst optimism. By monitoring changes in the consensus net income growth estimate, an investor assesses the risk of stock overvaluation. For United Therapeutics (UTHR), this trend depends directly on the commissioning of new sterile capacities and the scaling of drug production.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|BMRN (BioMarin Pharmaceutical Inc.) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BridgeBio BBIO|Expected earnings per share trend next year BGM|Cogent Biosciences - Earnings growth forecast for next year|Expected earnings per share trend next year XERS (Xeris Biopharma)|KROS: Earnings growth forecast for next year|Arcturus Therapeutics Inc (ARCT) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Eton Pharma|KMDA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year fulcrumtx.com (FULC)|Expected earnings per share growth for next year Abeona Therapeutics Inc. ABEO|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year